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Background
Vertical transmission represents the major route of HIV
infection for children; however, the preventive interventions
available are extremely effective. Then, we aim to summarize
the existing evidences regarding the cost-effectiveness of
mother-to-child-transmission preventive screenings, in order
to help policy makers in choosing the optimal antenatal
screening strategy.
Methods
We conducted a systematic review of studies investigating the
cost-effectiveness of HIV-screening addressed to pregnant
women following PRISMA guidelines, using three databases:
PubMed, Scopus and Cost-Effectiveness Analysis Registry
(CEA).
Results
The final selection obtained 21 papers. Part of the studies
assessed the cost-effectiveness of antenatal HIV-screening
during early gestation. Others estimated the cost-effectiveness
of HIV-screening in late pregnancy. The selected papers
focused on both developed and developing countries, char-
acterized by different HIV prevalence. The characteristics and
methodology of the retrieved studies were heterogeneous.
However, all studies agreed on main findings, outlining the
cost-effectiveness of HIV-screening. Cost-effectiveness ratio
improves increasing HIV burden. The major findings proved
robust across the various scenarios tested in sensitivity analysis.
Discussion
Our review confirmed the cost-effectiveness not only of HIV
antenatal screening, but also of rescreening in late gestation in
both developed and developing countries. In fact, universal
screening resulted cost-effective even with extremely low HIV
prevalence. One of the most influencing parameter was women
acceptance rate. Therefore, maximize screening coverage
appears a priority worldwide. Further studies assessing the
optimal HIV-test choice and the best testing sequence for
confirmation, could be useful and of primary importance for
the European public health agenda.
Key messages:
 Our review confirmed the cost-effectiveness not only of HIV
antenatal screening, but also of rescreening in late gestation
in both developed and developing countries
 HIV-screening for pregnant women resulted cost-effective
even when the HIV prevalence is extremely low, common in
several European Countries, and can be considered as a
prevention strategy in Europe
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